CClinicalTrials.gg
RecruitingNCT06528379GINGERUpdated Aug 2, 2024

Physical Activity Component of the Greek Interventional Geriatric Study to Prevent Cognitive Impairment and Disability (GINGER)

An interventional study of Physical Activity in People With Subjective Cognitive Impairement (SCI), sponsored by University of Patras. Recruiting at 2 sites in Greece. Open to participants aged 50 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-08-02.

Sponsored by University of Patras · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Started May 2024; still recruiting 2 years 4 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Not applicable
Ages
50 Years and older
Sex
All
01

Study summary

The Greek Interventional Geriatric Study to Prevent Cognitive Impairment and Disability (GINGER) is a six-month multimodal, multicenter study aimed at people with Subjective Cognitive Impairement (SCI).

One of the GINGER's interventional components is the Physcial Activity (PA) component, coordinated by the University of Patras.

This PA component's scope is to determine whether an enhanced individualized physical exercise intervention programme can improve cognitive changes, physical function, quality of life and wellbeing in people with subjective cognitive decline.

02

Conditions studied

  • People With Subjective Cognitive Impairement (SCI)
03

In context

Cognitive Dysfunction

3,843 studies on the registry are indexed under Cognitive Dysfunction; 1,100 are open to participants now.

This study's planned enrollment of 200 is above the median of 65 across 2,808 interventional studies indexed under Cognitive Dysfunction.

Browse Cognitive Dysfunction studies →

Lead sponsor

University of Patras is the lead sponsor of 69 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Subjective Cognitive Decline confirmed from the Subjctive Cognitive Decline Questionnaire (SCD - Q score >7)
  • Absence of objective cognitive imparement as confirmed from cognitive assessment tests (i.e. MoCA, Trail A \& B, Stroop, RCFT, FAS. )

Exclusion criteria

Exclusion Criteri include people with:

  • Mild Cognitive Impairement (MCI) or dementia
  • Chronic psychiatric or neurological disorders affecting cognition (i.e. bipolar disorder, schizophrenia, MS, TBI, Parkinson's disease etc.)
  • Unstable pathological diseases (i.e. uncontrolled hypothyrodism, athythmias, uncontrolled hypertension, high blood pressure at rest etc.)
  • Recent (\<6 month) surgery, which restrics active participation in exercise/physical activity
  • inadequate knowledge of Greek
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
200 participants (estimated)

Study arms

  • Experimental
    Physical Activity intervention

    This Physical Activity intervention arm is a 6-month excercise protocol for SCI people, delivered 3 times per week, comprising of 2 supervised group-based exercise sessions \& one home-based (unsupervised) one. The exercise programme is a progressive evidence-based tailored exercise regime comprising aerobic, resistance and balance exercises, applied at a moderate intensity (60-80% of targeted heart rate).

    Behavioral: Physical Activity

Interventions

  • BehavioralPhysical Activity

    The exercise programme is a 6-month progressive tailored-based exercise regime comprising * aerobic exercises (40-60%) * resistance exercises (20-40%) * balance with resistance exercises (20%) . This is peformed 3 times weekly, it is tailored to each individual but delivered in a small group-based manner. Two sessions are supervised by physiotherapist /exercise scientist and one session is unsupervised, home-based.

06

What researchers measure

Primary outcomes

  1. Balance

    The Greek version of the Mini-BESTest (Mini-Balance Evaluation Systems Test) is used to assess the balance of each participant comprising four primary assessment balance categories (anticipatory, reactive postural control, sensory orientation, dynamic gait). The Mini-BESTest focuses primarily on dynamic balance and contains 14 different balancing tasks, each scored from 0 (lowest level of function) to 2 (highest level of function). Thus, overall scores range from 0 (lowest level of function) to 28 (highest level of function) and subsequent subscales are scored as: Anticipatory tasts (0-6), Reactive Postural Control (0-6), Sensory Orientation (0-6) \& Dynamic Gait (0-10). Mini-BESTest takes about 10-15 minutes to be administered.

    Time frame: Baseline, midway (12-weeks), post-intervention (6months) & follow-up (3 months)

  2. Upper limb muscle strength

    The Hand Grip Strength test is an objective, established and standardised measure of upper limb muscle strength, comprising a standard electronic hand dynamometer (Jamar) for measuring muscle strength of the hand (measured in kgs).

    Time frame: Baseline, midway (12-weeks), post-intervention (6months) & follow-up (3 months)

  3. Lower limb muscle strength

    The lower limbs strength is measured using the 30 seconds Sit-to-Stand test, which is an objective, established and standardised measure of lower limb muscle strength. Participants are seated in the front part of a standard chair with their hands crossed in front of their chest, and they are asked to stand up completely (full extension of their knees) and sit back down to the chair as many times as possible during 30 seconds (measuring the repetitions).

    Time frame: Baseline, midway (12-weeks), post-intervention (6months) & follow-up (3 months)

  4. Aerobic capacity

    The 2 Minute Walk Test is an established and objective test for measuring aerobic capacity. Participants are placed in a hallway of nine meters and are asked to cover as much ground as they can in two minutes (measured in meters).

    Time frame: Baseline, midway (12-weeks), post-intervention (6months) & follow-up (3 months)

Secondary outcomes

  1. Fear of Falling

    The Greek version of the Falls Self-efficacy International Scale (FES-I_GREEK) is used to evaluate Fear of Falling. FES-I is a 16-item questionnaire with scores ranging from 16 to 64 points. Higher scores indicate higher fear and concern regarding falls.

    Time frame: Baseline, midway (12-weeks), post-intervention (6months) & follow-up (3 months)

  2. Physical Function

    The International Physical Activity Questionnaire (IPAQ- 7) is used to evaluate physical function. IPAQ-7 is a 7-item questionnaire that calculates the physical activities taken place the last week (measured in METs).

    Time frame: Baseline, midway (12-weeks), post-intervention (6months) & follow-up (3 months)

  3. Adherance to exercise

    The Exercise Adherance Rating Scale (EARS) is a validated and recently adapted into Greek outcome for measuring execise adhearance as well as the reasons of non-adhearing, comprising of 16 question items, exploring adhearance (6 question items) and reasons for adhearance/non-adhearance (10 items). Scores range from 0 (adherance) to 64 (non-adherance).

    Time frame: Baseline, midway (12-weeks), post-intervention (6months) & follow-up (3 months)

07

Study locations

2 of 2 sites recruiting
  • Laboratory of Clinical Physiotherapy and Research, Department of Physiotherapy, University of Patras
    Patra, Achaia 26504, Greece
    • Evdokia Billis · Contact
    • Eftychia Nastou · Contact
    Recruiting
  • Department of Psychiatry, School of Medicine, University of Patras
    Patra, 26504, Greece
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided — Yes, once we gather 50% of the data, we will be happy to share.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 2, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06528379
Lead sponsor
University of Patras
Collaborators
University Hospital of Patras, University Hospital of Crete
Responsible party
Evdokia Billis (Professor in Physiotherapy, University of Patras) — Principal investigator
First posted
Jul 30, 2024
Start date
May 20, 2024
Primary completion
Sep 30, 2026 (estimated)
Completion
Sep 30, 2026 (estimated)
Last update
Aug 2, 2024

Study contacts

Evdokia Billis, PhD
Contact
billis@upatras.gr
00306973047170
Eftychia Nastou, MSC
Contact
nastou.e@upatras.gr
00306948694966

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion